Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes

Journal of Experimental Medicine

Volumn 185, Issue 12, 1997, Pages 2171-2176

  Forssmann, Ulf ^a   Uguccioni, Managrazia ^a   Loetscher, Pius ^a,b   Dahinden, Clemens A ^b   Langen, Hanno ^c   Thelen, Marcus ^a   Baggiolini, Marco ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR;

AMINO ACID SEQUENCE; ANTIBODY RESPONSE; ARTICLE; BASOPHIL; CALCIUM MOBILIZATION; DESENSITIZATION; EOSINOPHIL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LEUKOCYTE; LYMPHOCYTIC INFILTRATION; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANIMALS; BASOPHILS; CHEMOKINES, CC; CHEMOTACTIC FACTORS, EOSINOPHIL; CHEMOTAXIS; CYTOKINES; EOSINOPHILS; HISTAMINE RELEASE; HUMANS; LEUKOTRIENE C4; MACACA MULATTA; MALE; MOLECULAR SEQUENCE DATA; RECEPTORS, CHEMOKINE; RECEPTORS, CYTOKINE;

EID: 0030980816     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.185.12.2171     Document Type: Article

References (32)

1. Baggiolini, M., B. Dewald, and B. Moser. 1994. Interleukin-8 and related chemotactic cytokines - CXC and CC chemokines. Adv. Immunol. 55:97-179.
2. Carr, M.W., S.J. Roth, E. Luther, S.S. Rose, and T.A. Springer. 1994. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc. Natl. Acad. Sci. USA. 91:3652-3656.
3. Loetscher, P., M. Seitz, M. Baggiolini, and B. Moser. 1996. Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes. J. Exp. Med. 184:569-577.
4. Kuna, P., S.R. Reddigan, D. Rucinski, J.J. Oppenheim, and A.P. Kaplan. 1992. Monocyte chemotactic and activating factor is a potent histamine-releasing factor for human basophils. J. Exp. Med. 175:489-493.
5. Alam, R., M.A. Lett-Brown, P.A. Forsythe, D.J. Anderson-Walters, C. Kenamore, C. Kormos, and J.A. Grant. 1992. Monocyte chemotactic and activating factor is a potent histamine-releasing factor for basophils. J. Clin. Invest. 89:723-728.
6. Weber, M., M. Uguccioni, B. Ochensberger, M. Baggiolini, I. Clark-Lewis, and C.A. Dahinden. 1995. Monocyte chemotactic protein MCP-2 activates human basophil and eosinophil leukocytes similar to MCP-3. J. Immunol. 154:4166-4172.
7. Dahinden, C.A., T. Geiser, T. Brunner, V. von Tscharner, D. Caput, P. Ferrara, A. Minty, and M. Baggiolini. 1994. Monocyte chemotactic protein 3 is a most effective basophil-and eosinophil-activating chemokine. J. Exp. Med. 179: 751-756.
8. Uguccioni, M., P. Loetscher, U. Forssmann, B. Dewald, H.D. Li, S.H. Lima, Y.L. Li, B. Kreider, G. Garotta, M. Thelen, and M. Baggiolini. 1996. Monocyte chemotactic protein 4 (MCP-4), a novel structural and functional analogue of MCP-3 and eotaxin. J. Exp. Med. 183:2379-2384.
9. Baggiolini, M., and C.A. Dahinden. 1994. CC chemokines in allergic inflammation. Immunol. Today. 15:127-133.
10. Fernandez, H.N., P.M. Henson, A. Otani, and T.E. Hugli. 1978. Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under simulated in vivo conditions. J. Immunol. 120:109-115.
11. Wardlaw, A.J., R. Moqbel, O. Cromwell, and A.B. Kay. 1986. Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. J. Clin. Invest. 78:1701-1706.
12. Rot, A., M. Krieger, T. Brunner, S.C. Bischoff, T.J. Schall, and C.A. Dahinden. 1992. RANTES and macrophage inflammatory protein 1α induce the migration and activation of normal human eosinophil granulocytes. J. Exp. Med. 176: 1489-1495.
13. Rand, T.H., W.W. Cruikshank, D.M. Center, and P.F. Weller. 1991. CD4-mediated stimulation of human eosinophils: lymphocyte chemoattractant factor and other CD4-binding ligands elicit eosinophil migration. J. Exp. Med. 173: 1521-1528.
14. Kitaura, M., T. Nakajima, T. Imai, S. Harada, C. Combadiere, H.L. Tiffany, P.M. Murphy, and O. Yoshie. 1996. Molecular cloning of human eotaxin, an eosinophil-selective CC chemokine, and identification of a specific eosinophil eotaxin receptor, CC chemokine receptor 3. J. Biol. Chem. 271: 7725-7730.
15. Ponath, P.D., S.X. Qin, D.J. Ringler, I. Clark-Lewis, J. Wang, N. Kassam, H. Smith, X.J. Shi, J.A. Gonzalo, W. Newman et al. 1996. Cloning of the human eosinophil chemoattractant, eotaxin - Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J. Clin. Invest. 97:604-612.
16. Daugherty, B.L., S.J. Siciliano, J.A. DeMartino, L. Malkowitz, A. Sirotina, and M.S. Springer. 1996. Cloning, expression, and characterization of the human eosinophil eotaxin receptor. J. Exp. Med. 183:2349-2354.
17. Baggiolini, M. 1996. Eotaxin: A VIC (very important chemokine) of allergic inflammation? J. Clin. Invest. 97:587.
18. Patel, V.P., B.L. Kreider, Y. Li, H. Li, K. Leung, T. Salcedo, B. Nardelli, V. Pippalla, S. Gentz, R. Thotakura et al. 1997. Molecular and functional characterization of two novel human chemokines as inhibitors of two distinct classes of myeloid progenitors. J. Exp. Med. 185:1163-1172.
19. Clark-Lewis, I., B. Moser, A. Walz, M. Baggiolini, G.J. Scott, and R. Aebersold. 1991. Chemical synthesis, purification, and characterization of two inflammatory proteins, neutrophil activating peptide 1 (interleukin-8) and neutrophil activating peptide 2. Biochemistry. 30:3128-3135.
20. Heath, H., S. Quin, P. Rao, L. Wu, G.J. LaRosa, N. Kassam, P.D. Ponath, and C.R. Mackay. 1997. Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody. J. Clin. Invest. 99:178-184.
21. Uguccioni, M., M. D'Apuzzo, M. Loetscher, B. Dewald, and M. Baggiolini. 1995. Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1α and MIP-1β on human monocytes. Eur. J. Immunol. 25:64-68.
22. Peveri, P., A. Walz, B. Dewald, and M. Baggiolini. 1988. A novel neutrophil-activating factor produced by human mononuclear phagocytes. J. Exp. Med. 167:1547-1559.
23. Bischoff, S.C., M. Krieger, T. Brunner, and C.A. Dahinden. 1992. Monocyte chemotactic protein 1 is a potent activator of human basophils. J. Exp. Med. 175:1271-1275.
24. Bischoff, S.C., M. Krieger, T. Brunner, A. Rot, V. von Tscharner, M. Baggiolini, and C.A. Dahinden. 1993. RANTES and related chemokines activate human basophil granulocytes through different G protein-coupled receptors. Eur. J. Immunol. 23:761-767.
25. von Tscharner, V., B. Prod'hom, M. Baggiolini, and H. Reuter. 1986. Ion channels in human neutrophils activated by a rise in free cytosolic calcium concentration. Nature (Lond.). 324:369-372.
26. Bischoff, S.C., and C.A. Dahinden. 1992. Effect of nerve growth factor on the release of inflammatory mediators by mature human basophils. Blood. 79:662-2669.
27. Baggiolini, M., B. Dewald, and B. Moser. 1997. Human chemokines: an update. Adv. Immunol. In press.
28. 2-terminal residues and evidence for uncoupling of neutrophil chemotaxis, exocytosis, and receptor binding activities. J. Biol. Chem. 266:23128-23134.
29. 2-terminal residues. J. Exp. Med. 181: 631-640.
30. 2-terminal residue converts monocyte chemotactic protein 1 from an activator of basophil mediator release to an eosinophil chemoattractant. J. Exp. Med. 183:681-685.
31. Griffiths-Johnson, D.A., P.D. Collins, A.G. Rossi, P.J. Jose, and T.J. Williams. 1993. The chemokine, eotaxin, activates guinea-pig eosinophils in vitro and causes their accumulation into the lung in vivo. Biochem. Biophys. Res. Commun. 197: 1167-1172.
32. Rothenberg, M.E., A.D. Luster, and P. Leder. 1995. Murine eotaxin: an eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor suppression. Proc. Natl. Acad. Sci. USA. 92:8960-8964.